Status:
UNKNOWN
The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease
Lead Sponsor:
Seoul National University Boramae Hospital
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
20-85 years
Phase:
PHASE4
Brief Summary
Background: Contrast-induced nephropathy (CIN) is a serious clinical problem associated with increased morbidity and mortality, particularly in patients with chronic renal insufficiency. Although som...
Detailed Description
All patients with CKD scheduled for CAG will be eligible, assuming their ability to understand the character and individual consequences of participation as well as giving written informed consent. CK...
Eligibility Criteria
Inclusion
- patient with chronic kidney disease scheduled for coronary angiogram
Exclusion
- age less than 20 years or more than 85 years
- liver cirrhosis greater than or equal to Child class B
- decreased serum platelet level (\< 100,000/uL)
- patients who received or are schedule to receive percutaneous renal intervention
- currently are taking anticoagulation drugs
- unable to give informed consent
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT01165567
Start Date
December 1 2009
End Date
December 1 2010
Last Update
July 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 156-707